With coronavirus cases around the world now at over 2.4 million, scientists have been frantically working to develop a vaccine.
Professor Adrian Hill, Director of the Jenner Institute at the University of Oxford: “Vaccines are being designed from scratch and progressed at an unprecedented rate. It was chosen as the most suitable vaccine for COVID-19 as it can generate a strong immune response from one dose, but is not a replicating virus.
Finally, Phase 3 will see 5,000 volunteers aged over 18 years tested, with half receiving the COVID-19 vaccine. They explained: “The best-case scenario is that by the autumn of 2020 we could have an efficacy result from the phase III trial to show that the vaccine protects against the virus, alongside the ability to manufacture large amounts of the vaccine, but these best-case timeframes are highly ambitious and subject to change.”